Inventia Life Science Unveils RASTRUM™ Allegro to Transform 3D Cell Culture in Drug Discovery and Disease Research
Inventia Life Science, a leader in 3D cell culture technologies, has announced the launch of RASTRUM™ Allegro, a revolutionary platform that enhances drug discovery and disease research. This next-generation 3D cell culture system is designed to offer unprecedented scalability, reproducibility, and efficiency, providing researchers with the tools to create biologically relevant models that replicate human biology more accurately than ever before.
Addressing Key Challenges in 3D Cell Culture
RASTRUM Allegro is a solution to the common challenges faced by researchers in the life sciences, particularly in creating consistent and scalable 3D cell models. Traditional 3D culture environments often struggle to maintain patient-derived cells, which are typically difficult to expand and sustain. These cells, vital for advancing biomedical research, often prove challenging to use with conventional 3D models, limiting their potential for providing deep biological insights.
With RASTRUM Allegro, researchers can now develop complex, reproducible 3D cell models with minimal hands-on time, allowing them to better simulate human disease biology. This platform is designed to be accessible to scientists, reducing the time and effort involved in creating 3D models, and making it possible to conduct high-throughput research that can drive breakthroughs in understanding and treatment.
Empowering Researchers with Precision and Scalability
According to Julio Ribeiro, Founder and CEO of Inventia Life Science, “Scientists know the value of biologically relevant models for advancing their work. We developed RASTRUM Allegro to give researchers the ability to generate complex 3D cell models that better represent human biology. The system provides the precision and scalability needed to fuel discovery and reveal deeper biological insights.”
RASTRUM Allegro is designed to make high-throughput 3D cell culture assays both fast and affordable. By reducing per-sample costs significantly, it allows researchers to explore more variables, ensuring they can generate meaningful insights while maintaining consistency across experiments. The system enhances the ability of researchers to conduct studies on a wider range of biological scenarios, providing them with data that is both reliable and impactful.
Innovation Aligned with Inventia’s Mission
The development of RASTRUM Allegro fits seamlessly within Inventia Life Science’s broader mission to advance biomedical research. The company has long been committed to providing cutting-edge tools that allow scientists to replicate disease biology at scale, enabling them to unlock new insights and develop more effective therapies.
“Our commitment is to help researchers unlock new biological insights with confidence,” said Ribeiro. “RASTRUM Allegro builds on our proven technology, making it easier for labs to adopt 3D models without compromising quality or accessibility.”
This innovation empowers researchers in multiple domains, from drug discovery to disease modeling, providing them with a platform that supports their work with high efficiency and precision.
Transforming Drug Discovery and Disease Modeling
RASTRUM Allegro is already changing the way drug discovery and disease modeling workflows are approached. Cameron Ferris, PhD, Chief Operating Officer at Inventia Life Science, emphasized the significant impact of the platform: “For years, researchers had to choose between biological complexity and scalability. RASTRUM Allegro eliminates that trade-off, enabling high-throughput 3D cell culture while maintaining reproducibility on par with 2D systems. This shift empowers researchers to explore complex disease phenotypes confidently and scale their experiments for more meaningful insights.”
One of the standout features of RASTRUM Allegro is its ability to deliver robust and reproducible results, even in high-throughput settings, which is essential for large-scale drug screening and patient-derived disease modeling. This capability is particularly crucial in studying diseases such as cancer, where traditional models often fail to provide accurate or scalable insights into how drugs will perform in the human body.
Key Benefits of RASTRUM Allegro
RASTRUM Allegro offers several significant advantages, which are transforming the landscape of 3D cell culture:
- Scalability and Speed: Researchers can generate 3D cell models rapidly—taking just 6 minutes for a 96-well plate and 9 minutes for a 384-well plate. This high throughput enables researchers to produce up to 35+ plates a day, greatly enhancing productivity and accelerating the pace of research.
- Reproducibility: The platform ensures consistent, high-quality results, both in basic research and drug discovery. The coefficient of variation (CV) for post-printing is less than 10%, and downstream assay CVs are under 19%, ensuring the reliability of experimental data.
- Efficiency: RASTRUM Allegro is optimized for patient-derived samples and translational research, enabling scientists to create up to 3.5 times more models from the same limited cell number compared to previous generations. This efficiency is a game-changer, especially when working with rare or hard-to-grow patient samples.
- Affordability: With lower costs per well, RASTRUM Allegro makes 3D cell culture more accessible to a broader range of research labs. This cost-effectiveness helps democratize access to high-quality 3D models, expanding the scope of research.
A Bold Vision for the Future
RASTRUM Allegro is more than just a technological advancement—it is a stepping stone towards the democratization of 3D cell culture technology. Julio Ribeiro concluded, “This is generational change for research and human health. We’re making 3D cell culture an everyday tool for labs worldwide, enabling new possibilities in disease understanding and therapeutic discovery.”
By making 3D cell culture models more accessible, affordable, and reproducible, Inventia Life Science is providing researchers with the tools they need to accelerate their work and drive discoveries that could have far-reaching implications for human health.
About Inventia Life Science
Inventia Life Science is a pioneer in 3D cell culture technology, driven by a mission to support researchers and pharmaceutical companies in their exploration of cell behaviors and treatment responses in environments that closely resemble the human body. Through its RASTRUM™ platform, the company integrates cutting-edge 3D cell model architectures, matrices, and precision drop-on-demand technology to provide deeper insights into complex biological systems. Inventia also offers comprehensive Discovery Services, helping to push the boundaries of biomedical research and accelerate the pace of scientific discovery. For more information, visit Inventia Life Science.
